August 26, 2025 – For the first time in Israel, Rambam Health Care Campus (Rambam) is testing a revolutionary gene-editing treatment that could halt a deadly form of heart failure. The same technology may soon target The post First in Israel: Gene-Editing Therapy for Heart Failure appeared first on American Friends of Rambam Medical Center.| American Friends of Rambam Medical Center
Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying heart failure.| Pulmonary Hypertension News
Kaiser Permanente study finds medication is still necessary for patients with a reduced ejection fraction that improves over time.| Kaiser Permanente Division of Research
The Aeson Total Artificial Heart helped three people with heart failure and pulmonary hypertension become eligible for a heart transplant.| Pulmonary Hypertension News
Sensydia has completed a development study of its Cardiac Performance System device to detect pulmonary hypertension and heart failure.| Pulmonary Hypertension News
Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing critical needs in cardiovascular health.| News-Medical
Heart failure related to PAH is becoming more common, with patients living fewer years in full health, a trend that’s predicted to continue.| Pulmonary Hypertension News
The patient is being seen for routine follow-up in the heart failure ... but has multiple comorbidities with potentially overlapping symptoms and hypotension limiting renal dialysis sessions.| iForumRx
The patient was referred by her community pharmacists after reporting frequent episodes of hypoglycemia. First visit to this family medicine practice. New onset leg pain and swelling over the past few days.| iForumRx
A major new study has finally confirmed the cause of soaring heart failure cases among children that are being reported all around the world.| Slay News